Effects of Vinclozolin on Prostate Development and Inflammation in Rats
Author Information
Author(s): Prue A. Cowin, Paul Foster, John Pedersen, Shelley Hedwards, Stephen J. McPherson, Gail P. Risbridger
Primary Institution: Monash University
Hypothesis
Does in utero exposure to the antiandrogenic EDC vinclozolin affect prostate gland function in male offspring?
Conclusion
In utero exposure to vinclozolin leads to early-onset prostatitis in male rats without causing premalignant lesions.
Supporting Evidence
- Vinclozolin exposure did not affect prostatic development until puberty.
- 100% of rats exposed to vinclozolin developed prostatitis by postpuberty.
- Inflammation was linked to activation of the NFκB signaling pathway.
- Prostatic inflammation did not lead to premalignant lesions in the study.
Takeaway
When baby rats were exposed to a chemical called vinclozolin before they were born, they later developed prostate inflammation, which is similar to a condition seen in some young men.
Methodology
Fetal rats were exposed to vinclozolin or vehicle control in utero, and prostate function was analyzed at different ages.
Limitations
The study used a high dose of vinclozolin that exceeds typical environmental exposure levels.
Participant Demographics
Outbred Sprague-Dawley rats were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website